156 related articles for article (PubMed ID: 38804379)
21. Cardiotoxicity among adult survivors suffered from childhood malignancies.
Petropoulos AC; Moschovi M
Hell J Nucl Med; 2019; 22 Suppl 2():34-40. PubMed ID: 31802042
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis.
Oikonomou EK; Kokkinidis DG; Kampaktsis PN; Amir EA; Marwick TH; Gupta D; Thavendiranathan P
JAMA Cardiol; 2019 Oct; 4(10):1007-1018. PubMed ID: 31433450
[TBL] [Abstract][Full Text] [Related]
23. Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.
de Baat EC; Mulder RL; Armenian S; Feijen EA; Grotenhuis H; Hudson MM; Mavinkurve-Groothuis AM; Kremer LC; van Dalen EC
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014638. PubMed ID: 36162822
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.
Bryant J; Picot J; Levitt G; Sullivan I; Baxter L; Clegg A
Health Technol Assess; 2007 Jul; 11(27):iii, ix-x, 1-84. PubMed ID: 17610809
[TBL] [Abstract][Full Text] [Related]
25. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
[TBL] [Abstract][Full Text] [Related]
26. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.
Larsen CM; Garcia Arango M; Dasari H; Arciniegas Calle M; Adjei E; Rico Mesa J; Scott CG; Thompson CA; Cerhan JR; Haddad TC; Goetz MP; Herrmann J; Villarraga HR
JAMA Netw Open; 2023 Feb; 6(2):e2254669. PubMed ID: 36735254
[TBL] [Abstract][Full Text] [Related]
27. Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms.
Yagi R; Goto S; Himeno Y; Katsumata Y; Hashimoto M; MacRae CA; Deo RC
Nat Commun; 2024 Mar; 15(1):2536. PubMed ID: 38514629
[TBL] [Abstract][Full Text] [Related]
28. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.
Drafts BC; Twomley KM; D'Agostino R; Lawrence J; Avis N; Ellis LR; Thohan V; Jordan J; Melin SA; Torti FM; Little WC; Hamilton CA; Hundley WG
JACC Cardiovasc Imaging; 2013 Aug; 6(8):877-85. PubMed ID: 23643285
[TBL] [Abstract][Full Text] [Related]
29. Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.
Yu AF; Mukku RB; Verma S; Liu JE; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
Breast Cancer Res Treat; 2017 Nov; 166(1):241-247. PubMed ID: 28710537
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of sacubitril-valsartan in cancer patients with heart failure.
Martín-Garcia A; López-Fernández T; Mitroi C; Chaparro-Muñoz M; Moliner P; Martin-Garcia AC; Martinez-Monzonis A; Castro A; Lopez-Sendon JL; Sanchez PL
ESC Heart Fail; 2020 Apr; 7(2):763-767. PubMed ID: 32022485
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.
Narayan HK; French B; Khan AM; Plappert T; Hyman D; Bajulaiye A; Domchek S; DeMichele A; Clark A; Matro J; Bradbury A; Fox K; Carver JR; Ky B
JACC Cardiovasc Imaging; 2016 Oct; 9(10):1131-1141. PubMed ID: 27085442
[TBL] [Abstract][Full Text] [Related]
33. Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation.
Roziakova L; Bojtarova E; Mistrik M; Dubrava J; Gergel J; Lenkova N; Mladosievicova B
J Exp Clin Cancer Res; 2012 Feb; 31(1):13. PubMed ID: 22321767
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic value of global longitudinal strain combined with cardiac biomarkers on early detection of anthracycline-related cardiac dysfunction.
Allam H; Kamal M; Bendary M; Osama A; El Eleimy HA; Bendary A
J Echocardiogr; 2023 Dec; 21(4):165-172. PubMed ID: 37453981
[TBL] [Abstract][Full Text] [Related]
35. Early evaluation of subclinical cardiotoxicity in patients with lung cancer receiving immune checkpoint inhibitors by cardiovascular magnetic resonance: a prospective observational study.
Liu J; Cao Y; Zhu K; Yao S; Yuan M; Kong X; Liu X; Li Y; Cui Y; Han X; Zhou X; Meng R; Shi H
Quant Imaging Med Surg; 2022 Oct; 12(10):4771-4785. PubMed ID: 36185042
[TBL] [Abstract][Full Text] [Related]
36. Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study.
Camilli M; Viscovo M; Felici T; Maggio L; Ballacci F; Carella G; Bonanni A; Lamendola P; Tinti L; Di Renzo A; Coarelli G; Galli E; Liuzzo G; Burzotta F; Montone RA; Sorà F; Sica S; Hohaus S; Lanza GA; Crea F; Lombardo A; Minotti G
Cardiooncology; 2024 Mar; 10(1):18. PubMed ID: 38532515
[TBL] [Abstract][Full Text] [Related]
37. Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied Manifestation.
Peleg Hasson S; Arnold J; Merdler I; Sivan A; Shamai S; Geva R; Merimsky O; Shachar E; Waissengrin B; Moshkovits Y; Arbel Y; Topilsky Y; Rozenbaum Z; Wolf I; Laufer-Perl M
J Immunother; 2021 Jun; 44(5):179-184. PubMed ID: 33950028
[TBL] [Abstract][Full Text] [Related]
38. Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial.
Meessen JMTA; Cardinale D; Ciceri F; Sandri MT; Civelli M; Bottazzi B; Cucchi G; Menatti E; Mangiavacchi M; Condorelli G; Barbieri E; Gori S; Colombo A; Curigliano G; Salvatici M; Pastori P; Ghisoni F; Bianchi A; Falci C; Cortesi P; Farolfi A; Monopoli A; Milandri C; Bregni M; Malossi A; Nassiacos D; Verusio C; Staszewsky L; Leone R; Novelli D; Balconi G; Nicolis EB; Franzosi MG; Masson S; Garlanda C; Mantovani A; Cipolla CM; Latini R;
ESC Heart Fail; 2020 Aug; 7(4):1452-1466. PubMed ID: 32358917
[TBL] [Abstract][Full Text] [Related]
39. Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy.
Chang HY; Lee CH; Su PL; Li SS; Chen MY; Chen YP; Hsu YT; Tsai WC; Liu PY; Chen TY; Liu YW
Sci Rep; 2021 Mar; 11(1):7100. PubMed ID: 33782513
[TBL] [Abstract][Full Text] [Related]
40. Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based Chemotherapy.
Wang L; Tan TC; Halpern EF; Neilan TG; Francis SA; Picard MH; Fei H; Hochberg EP; Abramson JS; Weyman AE; Kuter I; Scherrer-Crosbie M
Am J Cardiol; 2015 Aug; 116(3):442-6. PubMed ID: 26071994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
